EDAP - EDAP TMS S.A.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
3.21
+0.01 (+0.31%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close3.20
Open3.16
Bid0.00 x 1000
Ask0.00 x 2200
Day's Range3.10 - 3.29
52 Week Range2.07 - 4.25
Volume237,985
Avg. Volume641,465
Market Cap93.083M
Beta-0.37
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateMay 15, 2018 - May 21, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.25
Trade prices are not sourced from all markets
  • ACCESSWIRE5 days ago

    Wired News – RTI Surgical Commercially Launches Fortilink(R)-TS and -L IBF Systems with TETRAfuse 3D Technology

    LONDON, UK / ACCESSWIRE / June 14, 2018 / If you want access to our free research report on RTI Surgical, Inc. (NASDAQ: RTIX), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=RTIX as the Company's latest news hit the wire. On June 12, 2018, the Company announced that it has commercially launched Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology. The Fortilink-TS and -L Systems are intended for use in lumbar interbody fusion procedures at one or two adjoining levels in patients with degenerative disc disease.

  • ACCESSWIRE8 days ago

    Major Regulatory Changes & Recent FDA Win Could Create a 400%+ Gain For Investors Holding This Unknown Stock

    Remote patient monitoring, through smaller cheaper technology, is transforming medical care in the U.S. Cardiac care is a major beneficiary, and now major government agencies are signalling that this sector could be a top priority in the coming years. New medical device from Biotricity (BTCY) could shake up a handful of existing companies in cardiac remote monitoring, as their new device has some clear improvements over older technology. With revenue and new product announcements this year, BTCY could move significantly higher in 2018 and 2019.

  • Reuters11 days ago

    US STOCKS-iPhone worries weigh on Wall Street

    U.S. stock indexes were lower on Friday as shares of Apple and its suppliers fell, following a report that the iPhone maker was planning to produce fewer phones this year. Apple Inc was down 1.6 percent after a newspaper report said the company had asked its supply chain to manufacture about 20 percent fewer components for iPhones in the latter half of 2018. Investors were also cautious ahead of a contentious G7 summit in Canada, with U.S. President Donald Trump lashing out at Canada and the European Union on Friday, raising the specter of a trade war.

  • MarketWatch11 days ago

    EDAP's stock rockets on heavy volume after prostate treatment gets FDA marketing clearance

    Shares of EDAP TMS SA rocketed 57% in very active morning trade Friday, to pace the Nasdaq's gainers, after the France-based therapeutic ultrasound company said it received clearance from the U.S. Food and Drug Administration to market its Focal One device for the removal of prostate tissue.

  • Benzinga11 days ago

    Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Stocks hitting 52-week highs on June 7) Baxter International Inc (NYSE: BAX ) Bio-Rad Laboratories, ...

  • Benzinga11 days ago

    Benzinga Pro's 6 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Docusign Inc (NASDAQ: DOCU ) stock was trading higher ...

  • GlobeNewswire11 days ago

    EDAP TMS SA : EDAP Announces FDA Clearance for Focal One®

    Focal One fuses MR and 3D biopsy data with real-time ultrasound imaging, which allows urologists to view integrated, detailed 3D images of the prostate on a large monitor and direct high intensity ultrasound waves to ablate the targeted area. With Focal One, urology surgeons can establish precise contours around the diseased tissue and ablate an even smaller portion of the prostate.  This lessens the damage to healthy tissue, and minimizes side effects of incontinence and impotence for patients.  Using Focal One, surgeons can customize the HIFU procedure for each patient and each clinical condition.

  • Was EDAP TMS SA.’s (NASDAQ:EDAP) Earnings Decline Part Of A Broader Industry Downturn?
    Simply Wall St.last month

    Was EDAP TMS SA.’s (NASDAQ:EDAP) Earnings Decline Part Of A Broader Industry Downturn?

    When EDAP TMS SA. (NASDAQ:EDAP) announced its most recent earnings (31 December 2017), I did two things: looked at its past earnings track record, then look at what is happeningRead More...

  • ACCESSWIRElast month

    EDAP TMS SA Sponsored ADR to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 15, 2018 / EDAP TMS SA Sponsored ADR (NASDAQ: EDAP ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 15, 2018 at 8:30 AM Eastern Time. ...

  • GlobeNewswirelast month

    EDAP TMS SA : EDAP Reports 2018 First Quarter Results

    2018 Q1 total revenue records a 6% increase year-over-year Focal One Final Additional Information submitted to FDA early May EDAP to attend American Urological Association congress in San Francisco, May ...

  • GlobeNewswire2 months ago

    EDAP TMS SA : EDAP TMS SA to Announce First Quarter 2018 Financial Results on Monday, May 14

    LYON, France, May 2, 2018- EDAP TMS SA, the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2018, after the close ...

  • ACCESSWIRE2 months ago

    Free Research Report as Globus Achieved Record Quarterly Revenues; Adjusted EPS Rose 20.6%

    Stock Monitor: EDAP TMS Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 04, 2018 / Active-Investors.com has just released a free earnings report on Globus Medical, Inc. (NYSE: GMED ) ("Globus"). ...

  • GlobeNewswire2 months ago

    EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes

    Clinical Results Presented at the Southeastern Section of the American Urological Association. Confirms HIFU's Safety, Efficacy and Benefits for Patients' Quality Of Life. LYON, FRANCE, AUSTIN, TX-- APRIL ...

  • ACCESSWIRE3 months ago

    EDAP TMS SA Sponsored ADR to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 28, 2018 / EDAP TMS SA Sponsored ADR (NASDAQ: EDAP ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 28, 2018, at 8:30 AM Eastern ...

  • GlobeNewswire3 months ago

    EDAP TMS SA : EDAP Reports 2017 Annual Results

    2017 revenue on par with 2016; lower HIFU capital equipment sales offset by double-digit HIFU treatment revenue growth CMS issued C-Code allocation for reimbursement of HIFU for prostate tissue ablation ...

  • GlobeNewswire3 months ago

    EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure

    Insurer Takes its Cue from Updated NCCN Guidelines, Which Recognizes HIFU as Salvage Treatment for Prostate Cancer. Lyon, France, Austin, TX-- March 21, 2018- EDAP TMS SA today announced that CIGNA became ...

  • ACCESSWIRE7 months ago

    EDAP TMS SA Sponsored ADR to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 16, 2017 / EDAP TMS SA Sponsored ADR (NASDAQ: EDAP ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 16, 2017 at 8:30 AM ...

  • Does EDAP TMS SA’s (EDAP) Debt Level Pose A Serious Problem?
    Simply Wall St.7 months ago

    Does EDAP TMS SA’s (EDAP) Debt Level Pose A Serious Problem?

    EDAP TMS SA (NASDAQ:EDAP) is a small-cap stock with a market capitalization of USD $89.02M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies,Read More...

  • ACCESSWIRE8 months ago

    Corporate News Blog - EDAP Announces Agreement with Theraclion to Market Echopulse HIFU in France

    LONDON, UK / ACCESSWIRE / October 11, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for EDAP TMS S.A. (NASDAQ: EDAP ) ("EDAP"), following which ...